Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Integrated Research Limited ( (AU:IRI) ) just unveiled an announcement.
Integrated Research Limited reported its FY25 financial results, highlighting a strategic pivot towards product-led growth with a focus on new product development and commercialization. Despite a challenging year with a decrease in statutory revenue and net profit, the company saw a 31% increase in revenue from new clients and a 77% rise in consumption-based revenue. The launch of new products and a significant contract renewal with JP Morgan Chase are expected to bolster future growth, although market uncertainties in the Americas have posed challenges.
The most recent analyst rating on (AU:IRI) stock is a Buy with a A$0.70 price target. To see the full list of analyst forecasts on Integrated Research Limited stock, see the AU:IRI Stock Forecast page.
More about Integrated Research Limited
Integrated Research Limited is a leading global provider specializing in observability for business-critical IT ecosystems. The company focuses on product-led growth, offering innovative solutions like High Value Payments and Prognosis Elevate, catering primarily to financial institutions and IT operations.
Average Trading Volume: 200,812
Technical Sentiment Signal: Sell
Current Market Cap: A$80.7M
Find detailed analytics on IRI stock on TipRanks’ Stock Analysis page.